Novacyt Raises $2.3M to Support Launch of Cytology Platform in China | GenomeWeb

NEW YORK(GenomeWeb) – Novacyt said on Monday that it raised €2.2 million ($2.3 million) in a private equity placement. 

The financing will be used to accelerate the launch of the firm's cytology platform NovaPrep in China with its distribution partner, Danaher's Leica Biosystems. The firms announced a distribution agreement for that country last month. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.